Cefpodoxime Export Market Intelligence: India's 178 Suppliers Shipping to 78 Countries — TransData Nexus 2026

Q: Who are the top cefpodoxime exporters from India?

The top cefpodoxime exporters from India are: 1. ALKEM LABORATORIES LIMITED — $28.1M (35.3% market share); 2. AUROBINDO PHARMA LTD — $22.0M (27.7% market share); 3. LUPIN LIMITED — $10.6M (13.3% market share); 4. AUROBINDO PHARMA LIMITED — $7.5M (9.5% market share); 5. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $1.7M (2.1% market share). Together they account for 87.9% of India's total cefpodoxime export value.

Q: What is the total export value of cefpodoxime from India?

The total export value of cefpodoxime from India is $79.5M USD, recorded across 1,734 shipment transactions from 178 active exporters to 78 destination countries. The average shipment value is $45.9K.

Q: Which countries import cefpodoxime from India?

India exports cefpodoxime to 78 countries worldwide. The top importing countries are: UNITED STATES (69.6% share, $55.3M), FRANCE (5.8% share, $4.6M), SUDAN (3.8% share, $3.1M), VIETNAM (3.2% share, $2.6M), MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF (2.8% share, $2.2M). These five markets account for 85.2% of total export value.

Q: What is the HS code for cefpodoxime exports from India?

The primary HS code for cefpodoxime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of cefpodoxime exports from India?

The average unit price for cefpodoxime exports from India is $2.74 USD per unit, with prices ranging from $0.00 to $171.99 depending on formulation, packaging, and order volume. The total market is valued at $79.5M across 1,734 shipments.

Q: Which ports handle cefpodoxime exports from India?

The primary ports for cefpodoxime exports from India are NHAVA SHEVA SEA (INNSA1) (10.0% of shipments), SAHAR AIR (9.6% of shipments), JNPT/ NHAVA SHEVA SEA (7.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.4% of shipments), JNPT (5.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of cefpodoxime?

India is one of the world's leading exporters of cefpodoxime due to its large base of 178 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports cefpodoxime to 78 countries, demonstrating 40% global market coverage.

Q: What certifications do Indian cefpodoxime exporters need?

Indian cefpodoxime exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import cefpodoxime from India?

There are 442 registered buyers importing cefpodoxime from India, spread across 78 countries. The repeat buyer rate is 55.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top cefpodoxime supplier from India?

ALKEM LABORATORIES LIMITED is the leading cefpodoxime exporter from India with a market share of 35.3% and total export value of $28.1M across 29 shipments. The top 5 suppliers together control 87.9% of total export value.

Suresh Sormare

Cefpodoxime

India Pharmaceutical Trade Intelligence

$79.5M178 Suppliers78 CountriesHS 30042019

ExportsIndia → UNITED STATES69.6%India → FRANCE5.8%

ImportsUNITED STATES → India$865 FRANCE → India$34

#1 Supplier: ALKEM LABORATORIES

Cefpodoxime Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Cefpodoxime to the World

Between 2022 and 2026, India exported $79.5M worth of cefpodoxime across 1,734 verified shipments to 78 countries — covering 40% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED STATES (69.6%). ALKEM LABORATORIES LIMITED leads with a 35.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Cefpodoxime export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Cefpodoxime export data snapshot — $79.5M · 178 exporters · 78 countriesTransData Nexus · Indian Customs Data

Top Cefpodoxime Exporters from India

178 active exporters · Ranked by export value

View all 178 →

Top Cefpodoxime Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ALKEM LABORATORIES LIMITED	$28.1M	29	5	35.3%
2	AUROBINDO PHARMA LTD

Top Countries Importing Cefpodoxime from India

78 destination markets · Ranked by import value

All 78 countries →

Top Countries Importing Cefpodoxime from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$55.3M	69.6%
2	FRANCE	$4.6M	5.8%
3	SUDAN	$3.1M	3.8%
4	VIETNAM	$2.6M	3.2%
5	MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF	$2.2M	2.8%
6	GREECE	$1.5M	1.9%
7	SOUTH AFRICA	$1.5M	1.9%
8	GERMANY	$1.4M	1.8%
9	BELGIUM	$993.3K	1.2%
10	NORTH MACEDONIA	$782.3K	1.0%

UNITED STATES is India's largest cefpodoxime export destination, absorbing 69.6% of total exports worth $55.3M. The top 5 importing countries — UNITED STATES, FRANCE, SUDAN, VIETNAM, MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF — together account for 85.2% of India's total cefpodoxime export value. The remaining 73 destination countries collectively receive the other 14.8%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Cefpodoxime to India?

2 origin countries · Total import value: $899

India imports cefpodoxime from 2 countries with a combined import value of $899. The largest supplier is UNITED STATES ($865, 2 shipments), followed by FRANCE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Cefpodoxime to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$865	2	96.2%
2	FRANCE	$34	1	3.8%

UNITED STATES is the largest supplier of cefpodoxime to India, accounting for 96.2% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Cefpodoxime — Export Intelligence Video

Visual overview of India's cefpodoxime import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's cefpodoxime pharmaceutical import and export market — $79.5M in total trade, 178 verified manufacturers, and 78 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Cefpodoxime

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, cefpodoxime is approved for use as an antibiotic. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for cefpodoxime, indicating a competitive generic market. The regulatory pathway for cefpodoxime involves submission of an ANDA, demonstrating bioequivalence to the reference listed drug. Given that 69.6% of India's cefpodoxime exports are directed to the U.S., compliance with FDA regulations is paramount for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, cefpodoxime is subject to marketing authorization procedures overseen by the European Medicines Agency (EMA) and national competent authorities. The EMA has evaluated cefpodoxime-containing products, ensuring their safety and efficacy. Manufacturers must adhere to EU Good Manufacturing Practice (GMP) requirements, which are critical for maintaining product quality and facilitating market access. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates cefpodoxime, requiring compliance with similar standards.

3WHO Essential Medicines & Global Standards

Cefpodoxime is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in treating bacterial infections. This inclusion facilitates its adoption in national formularies and procurement by international health organizations. Compliance with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) is essential for ensuring product quality and acceptance in various markets.

4India Regulatory Classification

In India, cefpodoxime is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including cefpodoxime, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for cefpodoxime have expired, leading to a robust generic market with multiple manufacturers producing the antibiotic. This competitive landscape has contributed to the widespread availability and affordability of cefpodoxime globally.

6Recent Industry Developments

In January 2024, the FDA initiated a Class 2 device recall for BD BBL Sensi Disc Cefpodoxime due to quality concerns, highlighting the importance of stringent quality control measures in manufacturing. In July 2024, the EMA published a list of nationally authorized medicinal products containing cefpodoxime, reflecting ongoing regulatory oversight and market presence in the EU. These developments underscore the dynamic regulatory environment and the necessity for manufacturers to maintain compliance with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Cefpodoxime

Retail & reference prices across 9 markets vs. India FOB export price of $2.74/unit

Global Price Benchmark for Cefpodoxime across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, Cefpodoxime Proxetil is an approved generic drug.
United Kingdom	$1.60	GBP	Cefpodoxime is listed in the NHS Drug Tariff as a prescription-only medication.
Germany	$1.65	EUR	Cefpodoxime is included in the German Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) pricing system.
Australia	$1.40	AUD

Supply Chain Risk Assessment — Cefpodoxime

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Cefpodoxime, a third-generation cephalosporin antibiotic, is primarily manufactured in India, which has established itself as a significant producer of Active Pharmaceutical Ingredients (APIs). However, the production of these APIs is heavily reliant on Key Starting Materials (KSMs) sourced from China. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting a critical dependency in the pharmaceutical supply chain.

This dependency poses substantial risks, as any disruption in the supply of KSMs from China can lead to significant challenges in API production. For instance, in October 2025, stricter environmental regulations and plant closures in China led to a reduction in the manufacturing of Cefpodoxime Proxetil API, resulting in supply shortages and increased prices in the U.S. market.

2Supplier Concentration & Single-Source Risk

The export data for Cefpodoxime from India reveals a high level of supplier concentration. The top five exporters—Alkem Laboratories Limited, Aurobindo Pharma Ltd, Lupin Limited, Aurobindo Pharma Limited, and Sun Pharmaceutical Industries Limited—account for 87.9% of the total export value, with Alkem Laboratories Limited alone contributing 35.3%. This concentration indicates a significant single-source risk, as disruptions affecting these key suppliers could have a disproportionate impact on the global supply of Cefpodoxime.

Access Complete Cefpodoxime Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,734 transactions across 78 markets.

Request Demo View Pricing

Frequently Asked Questions — Cefpodoxime Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top cefpodoxime exporters from India?

The leading cefpodoxime exporters from India are ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, LUPIN LIMITED, and 12 others. ALKEM LABORATORIES LIMITED leads with 35.3% market share ($28.1M). The top 5 suppliers together control 87.9% of total export value.

What is the total export value of cefpodoxime from India?

The total export value of cefpodoxime from India is $79.5M, recorded across 1,734 shipments from 178 active exporters to 78 countries. The average shipment value is $45.9K.

Which countries import cefpodoxime from India?

India exports cefpodoxime to 78 countries. The top importing countries are UNITED STATES (69.6%), FRANCE (5.8%), SUDAN (3.8%), VIETNAM (3.2%), MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF (2.8%), which together account for 85.2% of total export value.

What is the HS code for cefpodoxime exports from India?

The primary HS code for cefpodoxime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cefpodoxime

Cefpodoxime

Top Cefpodoxime Exporters from India

Top Countries Importing Cefpodoxime from India

Who Supplies Cefpodoxime to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Cefpodoxime — Export Intelligence Video

Regulatory Landscape — Cefpodoxime

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Cefpodoxime

Supply Chain Risk Assessment — Cefpodoxime

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Cefpodoxime Trade Intelligence

Frequently Asked Questions — Cefpodoxime Exports from India

Who are the top cefpodoxime exporters from India?

What is the total export value of cefpodoxime from India?

Which countries import cefpodoxime from India?

What is the HS code for cefpodoxime exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of cefpodoxime exports from India?

Which ports handle cefpodoxime exports from India?

Why is India a leading exporter of cefpodoxime?

What certifications do Indian cefpodoxime exporters need?

How many buyers import cefpodoxime from India?

What is the market share of the top cefpodoxime exporter from India?

Analysis Methodology